{"id":"oxygen-21","safety":{"commonSideEffects":[{"rate":null,"effect":"Oxygen toxicity"},{"rate":null,"effect":"Pulmonary complications"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"This investigational therapy delivers a higher concentration of oxygen (21% is standard room air; this likely refers to enriched oxygen or a specific formulation) to increase dissolved oxygen in blood and improve oxygen delivery to tissues. The mechanism is based on enhancing aerobic metabolism and reducing hypoxia-related pathology in target tissues.","oneSentence":"Oxygen 21% is a hyperoxic gas mixture that increases arterial oxygen partial pressure to enhance tissue oxygenation and potentially promote healing or therapeutic benefit in hypoxic conditions.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T01:25:13.158Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Hypoxic conditions or tissue hypoxia (specific indication unclear from limited information)"}]},"trialDetails":[{"nctId":"NCT04759586","phase":"PHASE3","title":"Nivolumab in Combination With Chemo-Immunotherapy for the Treatment of Newly Diagnosed Primary Mediastinal B-Cell Lymphoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2021-10-05","conditions":"Primary Mediastinal Large B-Cell Lymphoma","enrollment":244},{"nctId":"NCT05377424","phase":"PHASE1, PHASE2","title":"Adenosine 2A Receptor Antagonism and AIH in ALS","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Florida","startDate":"2022-06-21","conditions":"ALS","enrollment":40},{"nctId":"NCT06169215","phase":"PHASE2","title":"Comparing the Combination of Selinexor-Daratumumab-Velcade-Dexamethasone (Dara-SVD) With the Usual Treatment (Dara-RVD) for High-Risk Newly Diagnosed Multiple Myeloma","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2024-07-23","conditions":"Multiple Myeloma","enrollment":70},{"nctId":"NCT05886036","phase":"PHASE2","title":"Comparing the Effectiveness of the Immunotherapy Agents Rituximab or Mosunetuzumab in Patients With Nodular Lymphocyte-Predominant Hodgkin Lymphoma, NORM Trial","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2024-01-23","conditions":"Nodular Lymphocyte Predominant B-Cell Lymphoma, Recurrent Nodular Lymphocyte Predominant B-Cell Lymphoma, Refractory Nodular Lymphocyte Predominant B-Cell Lymphoma","enrollment":70},{"nctId":"NCT07497230","phase":"NA","title":"Asymmetric High-Flow Nasal Cannula During Pulmonary Rehabilitation in COPD","status":"COMPLETED","sponsor":"Universidad de Santiago de Chile","startDate":"2025-05-02","conditions":"Pulmonary Disease, Chronic Obstructive (COPD), Dyspnea, Exercise Tolerance","enrollment":30},{"nctId":"NCT06948084","phase":"PHASE2","title":"Testing the Investigational Medication Combination of Daratumumab and Teclistamab Compared to the Usual Treatment (Daratumumab, Pomalidomide, Dexamethasone or Daratumumab, Carfilzomib, Dexamethasone) for Patients With High-risk Multiple Myeloma Refractory or in First Relapse","status":"NOT_YET_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2026-04-29","conditions":"Recurrent Multiple Myeloma, Refractory Multiple Myeloma","enrollment":80},{"nctId":"NCT06337318","phase":"PHASE3","title":"Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular Lymphoma","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2024-10-23","conditions":"Classic Follicular Lymphoma, Follicular Lymphoma With Unusual Cytological Features","enrollment":600},{"nctId":"NCT07487259","phase":"","title":"Impact of the Early Life Virome Development on Bronchopulmonary Dysplasia in Preterm Neonates","status":"NOT_YET_RECRUITING","sponsor":"Hospices Civils de Lyon","startDate":"2026-04-01","conditions":"Bronchopulmonary Dysplasia (BPD)","enrollment":40},{"nctId":"NCT05217498","phase":"PHASE1, PHASE2","title":"Combining Low Oxygen Therapy and an Adenosine A2a Receptor Antagonist to Improve Functional Mobility After Spinal Cord Injury","status":"NOT_YET_RECRUITING","sponsor":"Randy Trumbower, PT, PhD","startDate":"2027-09-01","conditions":"Spinal Cord Injuries, Myelopathy","enrollment":40},{"nctId":"NCT06932640","phase":"","title":"Continuous Assessment of Brain Blood Perfusion in Subarachnoid Hemorrhage Patients Using Near-Infrared Spectroscopy (NIRS)","status":"NOT_YET_RECRUITING","sponsor":"University of Alabama at Birmingham","startDate":"2026-07-01","conditions":"Subarachnoid Hemorrhage, Aneurysmal","enrollment":120},{"nctId":"NCT06276634","phase":"NA","title":"Intermittent Hypoxia in Persons With Multiple Sclerosis","status":"RECRUITING","sponsor":"Shirley Ryan AbilityLab","startDate":"2024-04-30","conditions":"Multiple Sclerosis, Multiple Sclerosis-Relapsing-Remitting, Multiple Sclerosis, Secondary Progressive","enrollment":21},{"nctId":"NCT02274116","phase":"NA","title":"Acute Intermittent Hypoxia on Leg Function Following Spinal Cord Injury","status":"ACTIVE_NOT_RECRUITING","sponsor":"Spaulding Rehabilitation Hospital","startDate":"2014-10","conditions":"Spinal Cord Injuries","enrollment":30},{"nctId":"NCT07483684","phase":"PHASE3","title":"A Clinical Study to Evaluate Injection TQB2102 for the Treatment of Patients With HER2 IHC3+ Advanced Colorectal Cancer Who Progressed After Treatment With Oxaliplatin, Irinotecan and Fluoropyrimidine-Based Drugs","status":"NOT_YET_RECRUITING","sponsor":"Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.","startDate":"2026-03","conditions":"HER2 IHC3+ Advanced Colorectal Cancer","enrollment":142},{"nctId":"NCT07317401","phase":"NA","title":"Investigating the Effects of Intermittent Hypoxia-Hyperoxia Treatment (IHHT) in People With Post-Viral Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) to Improve Fatigue, Pain, and Quality of Life by Targeting Mitochondrial Dysfunction and Autonomic Nervous System Impairment","status":"NOT_YET_RECRUITING","sponsor":"University of Aarhus","startDate":"2026-06-01","conditions":"Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) (ICD-10 G93.3)","enrollment":104},{"nctId":"NCT06925646","phase":"","title":"Hand Perfusion and Pulse Oximetry Performance","status":"NOT_YET_RECRUITING","sponsor":"Mayo Clinic","startDate":"2026-09-01","conditions":"Oxygen Saturation","enrollment":20},{"nctId":"NCT02464696","phase":"NA","title":"Non-invasive Ventilation in Reducing the Need for Intubation in Patients With Cancer and Respiratory Failure","status":"RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2015-10-06","conditions":"Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm","enrollment":256},{"nctId":"NCT07420530","phase":"EARLY_PHASE1","title":"Respiratory and Real-time Dynamics in Exercise-Induced Paradoxical Vocal Fold Motion","status":"RECRUITING","sponsor":"Indiana University","startDate":"2026-04-20","conditions":"Exercise-Induced Vocal Cord Dysfunction, Paradoxical Vocal Fold Motion, Vocal Cord Dysfunction","enrollment":120},{"nctId":"NCT07435389","phase":"NA","title":"VENTILATION DURING SPACEFLIGHT (PHASE 2)","status":"NOT_YET_RECRUITING","sponsor":"Centre Hospitalier Régional Metz-Thionville","startDate":"2026-03-16","conditions":"Non-invasive Ventilation","enrollment":12},{"nctId":"NCT04368039","phase":"NA","title":"Normobaric Oxygen Therapy for Individuals With First-Episode Psychosis","status":"RECRUITING","sponsor":"Nicholas Breitborde","startDate":"2019-12-04","conditions":"Psychosis, Schizophrenia, First-episode Psychosis","enrollment":20},{"nctId":"NCT06390930","phase":"NA","title":"Effects of Acute Intermittent Hypoxia on Neuroplasticity in MS","status":"RECRUITING","sponsor":"Shirley Ryan AbilityLab","startDate":"2025-02-01","conditions":"Multiple Sclerosis, Multiple Sclerosis, Relapsing-Remitting, Multiple Sclerosis, Secondary Progressive","enrollment":22},{"nctId":"NCT06413602","phase":"NA","title":"The Synergistic Effects of AIH and FES in Persons With MS","status":"ACTIVE_NOT_RECRUITING","sponsor":"Shirley Ryan AbilityLab","startDate":"2024-11-01","conditions":"Multiple Sclerosis, Multiple Sclerosis, Relapsing-Remitting, Multiple Sclerosis, Secondary Progressive","enrollment":40},{"nctId":"NCT06452095","phase":"NA","title":"Recovering From COVID-19 Lingering Symptoms Adaptive Integrative Medicine Trial - Effect of Hyperbaric Oxygen Therapy for the Treatment of Post COVID Condition","status":"RECRUITING","sponsor":"University Health Network, Toronto","startDate":"2026-01-01","conditions":"Long COVID, Post Acute Sequelae of COVID-19, Post-COVID-19 Condition","enrollment":120},{"nctId":"NCT07423273","phase":"NA","title":"Hyperbaric Oxygen Therapy for Persistent Post Stroke Depression","status":"RECRUITING","sponsor":"Assaf-Harofeh Medical Center","startDate":"2023-11-08","conditions":"Post Stroke Depression","enrollment":142},{"nctId":"NCT07424053","phase":"NA","title":"Effect of Graphene Oxide on Vital and Non-Vital Primary Teeth Compared to the Conventional Techniques","status":"NOT_YET_RECRUITING","sponsor":"Al-Azhar University","startDate":"2026-04","conditions":"Primary Teeth Indicated for Pulp Therapy","enrollment":126},{"nctId":"NCT07082270","phase":"PHASE1","title":"Selvigaltin With Standard of Care Treatment for the Treatment of Relapsed/Refractory Multiple Myeloma","status":"NOT_YET_RECRUITING","sponsor":"Roswell Park Cancer Institute","startDate":"2026-04-01","conditions":"Recurrent Multiple Myeloma, Refractory Multiple Myeloma","enrollment":21},{"nctId":"NCT04890639","phase":"NA","title":"Acute Intermittent Hypoxia in Traumatic Brain Injury","status":"COMPLETED","sponsor":"Shirley Ryan AbilityLab","startDate":"2022-03-15","conditions":"Brain Injuries, Traumatic","enrollment":12},{"nctId":"NCT02339740","phase":"PHASE3","title":"Tretinoin and Arsenic Trioxide in Treating Patients With Untreated Acute Promyelocytic Leukemia","status":"ACTIVE_NOT_RECRUITING","sponsor":"Children's Oncology Group","startDate":"2015-07-21","conditions":"Acute Promyelocytic Leukemia With t(15;17)(q24.1;q21.2); PML-RARA","enrollment":158},{"nctId":"NCT07405281","phase":"NA","title":"the Efficacy of Hyperbaric Oxygen on Acute Ankle Sprain","status":"NOT_YET_RECRUITING","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2026-03","conditions":"Ankle Sprain","enrollment":208},{"nctId":"NCT05082259","phase":"PHASE1","title":"ASTEROID: A Trial of ASTX660 in Combination With Pembrolizumab","status":"RECRUITING","sponsor":"Institute of Cancer Research, United Kingdom","startDate":"2022-03-02","conditions":"Advanced Cancer, Cervical Cancer, Triple Negative Breast Cancer","enrollment":61},{"nctId":"NCT07394699","phase":"NA","title":"Efficiency of Intermittent Hypoxia Intervention in Primary Insomnia","status":"NOT_YET_RECRUITING","sponsor":"Capital Medical University","startDate":"2026-04-01","conditions":"Insomnia, Primary","enrollment":30},{"nctId":"NCT07384403","phase":"PHASE4","title":"Application of Topical Oxygen Therapy Around Customized Healing Collar","status":"RECRUITING","sponsor":"Cairo University","startDate":"2026-01-01","conditions":"Soft Tissue, Healing Abutment Influence on Gingival Volume, Soft Tissue Healing","enrollment":6},{"nctId":"NCT07308171","phase":"NA","title":"Nasal Airflow to Modulate Dyspnea in Tracheostomized Patients","status":"NOT_YET_RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2026-02","conditions":"Ventilated Patients","enrollment":24},{"nctId":"NCT06658535","phase":"PHASE1","title":"A Dose Escalation Study of NanO2 in Patients With Mild Respiratory Distress","status":"RECRUITING","sponsor":"NuvOx LLC","startDate":"2025-03-13","conditions":"Mild Respiratory Distress","enrollment":18},{"nctId":"NCT07186192","phase":"PHASE3","title":"Digital Health Intervention for Self-Management and Telemonitoring in Chimeric Antigen Receptor (CAR-T) Therapy","status":"RECRUITING","sponsor":"City of Hope Medical Center","startDate":"2026-01-14","conditions":"Hematologic Malignancies","enrollment":190},{"nctId":"NCT06520358","phase":"NA","title":"Acute Intermittent Hypoxia to Improve Airway Protection in Chronic Traumatic Brain Injury","status":"COMPLETED","sponsor":"University of Florida","startDate":"2024-08-30","conditions":"Traumatic Brain Injury","enrollment":5},{"nctId":"NCT05464329","phase":"PHASE1","title":"Mosunetuzumab in Combination With Platinum-Based Salvage Chemotherapy in Patients With Relapsed/Refractory Aggressive B Cell Lymphoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"Washington University School of Medicine","startDate":"2023-01-03","conditions":"Large B-cell Lymphoma, High-grade B-cell Lymphoma, Transformed B-Cell Lymphoma","enrollment":24},{"nctId":"NCT05987852","phase":"NA","title":"Hyperbaric Oxygen Therapy for Ulcerative Colitis (HBOT-UC)","status":"RECRUITING","sponsor":"Northwestern University","startDate":"2024-01-09","conditions":"Ulcerative Colitis","enrollment":126},{"nctId":"NCT00338065","phase":"NA","title":"External Influences Upon Ocular Homeostasis","status":"ENROLLING_BY_INVITATION","sponsor":"Vanderbilt University Medical Center","startDate":"2006-06","conditions":"Intraocular Pressure","enrollment":200},{"nctId":"NCT02812979","phase":"NA","title":"Evaluation of the Effectiveness of the Nebulization Bronchodilators Under High Nasal Flow Humidified","status":"COMPLETED","sponsor":"University Hospital, Tours","startDate":"2016-06","conditions":"Chronic Obstructive Pulmonary Disease","enrollment":25},{"nctId":"NCT07295106","phase":"NA","title":"Personalized Music Therapy for Preterm Infants","status":"RECRUITING","sponsor":"Fabrizio Faina","startDate":"2025-10-13","conditions":"Infant, Premature, Stress, Psychological","enrollment":20},{"nctId":"NCT05455697","phase":"PHASE1, PHASE2","title":"Tafasitamab, Retifanlimab, and Rituximab in Combination With Standard Therapy for the Treatment of Diffuse Large B-cell Lymphoma","status":"RECRUITING","sponsor":"University of Washington","startDate":"2023-01-26","conditions":"Diffuse Large B-Cell Lymphoma, Grade 3b Follicular Lymphoma, High Grade B-Cell Lymphoma","enrollment":35},{"nctId":"NCT02754583","phase":"PHASE3","title":"Sanitation, Water, and Instruction in Face-washing for Trachoma I/II","status":"COMPLETED","sponsor":"University of California, San Francisco","startDate":"2015-12-05","conditions":"Trachoma","enrollment":47605},{"nctId":"NCT07002437","phase":"NA","title":"Hypoxia Pathways for Early Recovery After Spinal Cord Injury","status":"RECRUITING","sponsor":"University of Florida","startDate":"2025-11-20","conditions":"Spinal Cord Injuries (SCI)","enrollment":18},{"nctId":"NCT07159022","phase":"NA","title":"High Flow Nasal Cannula and Mask Oxygenation in Patients With Visceral Obesity Undergoing Sedated Gastroscopy","status":"RECRUITING","sponsor":"Shanghai Zhongshan Hospital","startDate":"2025-08-31","conditions":"High Flow Nasal Cannula, Body Roundness Index","enrollment":200},{"nctId":"NCT07235345","phase":"NA","title":"To Investigate the Effect of Pulmonary Surfactant With Different Inspired Oxygen Concentrations on the Clinical Outcomes of Very Preterm Infants Under Non-invasive Assisted Ventilation","status":"ENROLLING_BY_INVITATION","sponsor":"Xu Falin","startDate":"2025-09-04","conditions":"Neonatal Respiratory Distress Syndrome","enrollment":500},{"nctId":"NCT06581003","phase":"PHASE3","title":"Hyperbaric Oxygen Treatment for Veterans With Traumatic Brain Injury","status":"RECRUITING","sponsor":"University of South Florida","startDate":"2024-09-18","conditions":"Traumatic Brain Injury, Military Operations","enrollment":420},{"nctId":"NCT05527704","phase":"PHASE3","title":"the Inhaled β2-adrenergic Receptor Agonist for Transient Tachypnoea of the Newborn (the REFSAL Trial)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Medical University of Warsaw","startDate":"2021-12-31","conditions":"TTN, Respiratory Failure, PPHN","enrollment":608},{"nctId":"NCT06614309","phase":"NA","title":"Non-invasive Treatment for Long COVID (Post COVID-19 Condition) Brain Fog","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2024-09-24","conditions":"Long COVID","enrollment":45},{"nctId":"NCT06011876","phase":"NA","title":"BioFLO for Respiratory Recovery in SCI","status":"RECRUITING","sponsor":"University of Florida","startDate":"2023-12-21","conditions":"Spinal Cord Injuries","enrollment":62},{"nctId":"NCT07220187","phase":"PHASE3","title":"Adding Pirtobrutinib to the Usual Treatment for People With Newly Diagnosed Richter Transformation, The PIRAMID Trial","status":"NOT_YET_RECRUITING","sponsor":"SWOG Cancer Research Network","startDate":"2026-05-02","conditions":"Richter Syndrome, Transformed Chronic Lymphocytic Leukemia to Diffuse Large B-Cell Lymphoma, Transformed Small Lymphocytic Lymphoma to Diffuse Large B-Cell Lymphoma","enrollment":102},{"nctId":"NCT05924022","phase":"PHASE1","title":"Hyperbaric Oxygen Treatment (HBOT) During Methadone Tapering","status":"ACTIVE_NOT_RECRUITING","sponsor":"Washington State University","startDate":"2023-12-04","conditions":"Opioid Use Disorder","enrollment":36},{"nctId":"NCT05351827","phase":"NA","title":"Mild Intermittent Hypoxia: A Prophylactic for Autonomic Dysfunction in Individuals With Spinal Cord Injuries","status":"RECRUITING","sponsor":"VA Office of Research and Development","startDate":"2022-10-01","conditions":"Spinal Cord Injuries, Autonomic Dysreflexia","enrollment":24},{"nctId":"NCT04447716","phase":"PHASE1","title":"An Early Phase Study of Venetoclax, Lenalidomide, and Rituximab/Hyaluronidase in Slow-Growing Lymphomas That Have Come Back After Treatment or Have Not Responded to Treatment","status":"ACTIVE_NOT_RECRUITING","sponsor":"Thomas Jefferson University","startDate":"2020-10-16","conditions":"Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent Follicular Lymphoma, Recurrent Indolent Adult Non-Hodgkin Lymphoma","enrollment":4},{"nctId":"NCT06522971","phase":"NA","title":"Effects of Physical Exercise on Response to Treatement in Breast Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Latvian Biomedical Research and Study Centre","startDate":"2022-08-16","conditions":"Breast Cancer","enrollment":55},{"nctId":"NCT06713213","phase":"NA","title":"Clinical Comparison of Flow Regulated Nasal Oxygen Delivery System (FRNDS) Cannula and Plethysmography Belts","status":"COMPLETED","sponsor":"Virginia Polytechnic Institute and State University","startDate":"2025-04-01","conditions":"Respiratory Failure With Hypoxia","enrollment":57},{"nctId":"NCT07157657","phase":"PHASE2","title":"Efficacy of a Photosynthetic Dermal Matrix for the Treatment of Full-Thickness Skin Wounds","status":"RECRUITING","sponsor":"Pontificia Universidad Catolica de Chile","startDate":"2025-06-24","conditions":"Cronic Full-thinkness Skin Wound, Acute Full-thickness Skin Wound","enrollment":20},{"nctId":"NCT07031388","phase":"NA","title":"Mouthwashes for Gingivitis: Comparing a Hydrogen Peroxide-Hyaluronic Acid Mix, Hyaluronic Acid, and Chlorhexidine, A Triple-Blind Clinical Trial","status":"ACTIVE_NOT_RECRUITING","sponsor":"Ramziyah Hayder Bakr","startDate":"2025-07-01","conditions":"Plaque Induced Gingival Disease","enrollment":80},{"nctId":"NCT05498220","phase":"PHASE2","title":"Polatuzumab Vedotin With R-GDP in Relapsed/Refractory Diffuse Large B-cell Lymphoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"UNC Lineberger Comprehensive Cancer Center","startDate":"2023-02-17","conditions":"Diffuse Large B-cell Lymphoma","enrollment":5},{"nctId":"NCT04042298","phase":"","title":"Microvascular Function in Patients Undergoing 5-Fluorouracil Chemotherapy","status":"COMPLETED","sponsor":"Kansas State University","startDate":"2019-06-25","conditions":"Gastrointestinal Cancer, Head and Neck Cancer, Breast Cancer","enrollment":62},{"nctId":"NCT05343312","phase":"PHASE4","title":"In Vivo Efficacy of Artemether-Lumefantrine, Amodiaquine-Artesunate, Dihydroartemisinin-Piperaquine, and Pironaridine-Artesunate in Mozambique","status":"COMPLETED","sponsor":"Centro de Investigacao em Saude de Manhica","startDate":"2022-03-16","conditions":"Malaria","enrollment":870},{"nctId":"NCT07086742","phase":"NA","title":"Validation of the Smart Mask V1 System and Its Measurements of SpO2 and Pulse Rate","status":"RECRUITING","sponsor":"Pathway Medtech, LLC.","startDate":"2025-09-01","conditions":"Sleep-disordered Breathing (SDB), Sleep Apnea, Sleep Quality","enrollment":36},{"nctId":"NCT07125989","phase":"NA","title":"Effect of Exercise Ventilatory Support Pressure on Endurance in Patients With Severe Chronic Obstructive Pulmonary Disease - AVE-BPCO","status":"NOT_YET_RECRUITING","sponsor":"Centre Hospitalier Universitaire de Saint Etienne","startDate":"2025-10-01","conditions":"Chronic Obstructive Pulmonary Disease (COPD)","enrollment":30},{"nctId":"NCT04725539","phase":"NA","title":"Hypoxia Pre-conditioning and Mountain Sport","status":"COMPLETED","sponsor":"Institute of Mountain Emergency Medicine","startDate":"2022-01-01","conditions":"Coronary Artery Disease (CAD)","enrollment":17},{"nctId":"NCT06361420","phase":"NA","title":"Driving Pressure-guided Lung Protective Ventilation","status":"RECRUITING","sponsor":"Yong Lin, PhD","startDate":"2024-01-26","conditions":"Hypoxemia, Ventilator Lung","enrollment":43},{"nctId":"NCT06301035","phase":"NA","title":"Asymmetric High-flow Nasal Cannula (HFNC) vs Standard HFNC for Post Extubation High-risk Group","status":"COMPLETED","sponsor":"Samsung Medical Center","startDate":"2024-06-20","conditions":"Acute Respiratory Failure","enrollment":30},{"nctId":"NCT07096830","phase":"NA","title":"Efficacy of Tetrachlorodecaoxide (TCDO) Drops in Chronic Wound Healing","status":"NOT_YET_RECRUITING","sponsor":"Fazeelat Bibi","startDate":"2025-08-30","conditions":"Chronic Wound Care","enrollment":66},{"nctId":"NCT06670222","phase":"PHASE1","title":"Oral Arsenic (ATO) in Low-risk Myelodysplastic Syndromes (MDS)","status":"RECRUITING","sponsor":"Groupe Francophone des Myelodysplasies","startDate":"2025-07-22","conditions":"Low-risk Myelodysplastic Syndromes","enrollment":24},{"nctId":"NCT07095478","phase":"PHASE2","title":"Safety and Efficacy of Oral Artesunate for Pre-cervical Cancer","status":"NOT_YET_RECRUITING","sponsor":"Metanoic Health Ltd.","startDate":"2025-08-01","conditions":"CIN 2/3","enrollment":28},{"nctId":"NCT03976180","phase":"NA","title":"High-flow Oxygen for Vaso-occlusive Pain Crisis","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2020-04-27","conditions":"Sickle Cell Disease","enrollment":350},{"nctId":"NCT03644277","phase":"NA","title":"A Multi-Center Clinical Trial in Individuals With Spinal Cord Injury","status":"ACTIVE_NOT_RECRUITING","sponsor":"Shirley Ryan AbilityLab","startDate":"2018-07-01","conditions":"Spinal Cord Injuries","enrollment":121},{"nctId":"NCT06998563","phase":"","title":"The Effect of Lower Extremity Rotational Profile on Postural Control, Muscle Strength, Functional Capacity and Lower Extremity Function in Children With Generalized Joint Hypermobility","status":"COMPLETED","sponsor":"Bezmialem Vakif University","startDate":"2025-07-01","conditions":"Joint Hypermobility, Femoral Anteversion, Postural Control","enrollment":48},{"nctId":"NCT04287959","phase":"NA","title":"SWISH Trial (Strategies for Weaning Infants on Supportive High Flow)","status":"COMPLETED","sponsor":"Cardiff and Vale University Health Board","startDate":"2023-10-06","conditions":"Respiratory Disease, Bronchiolitis, Viral, Infant Morbidity","enrollment":20},{"nctId":"NCT05526534","phase":"NA","title":"A RCT on the Preventive Effect of HFNC on Postoperative Pulmonary Complications in Patients With Gynecologic Neoplasms","status":"RECRUITING","sponsor":"Sichuan Cancer Hospital and Research Institute","startDate":"2022-11-01","conditions":"Gynecologic Surgery, High-flow Nasal Cannula, Post-operative Pulmonary Complications","enrollment":200},{"nctId":"NCT05011877","phase":"","title":"The Simplify Project","status":"RECRUITING","sponsor":"Unity Health Toronto","startDate":"2021-09-01","conditions":"Acute Hypercapnic Respiratory Failure","enrollment":50},{"nctId":"NCT04517344","phase":"NA","title":"High Flow Nasal Cannula (HFNC) Initiation Flow Rate Study","status":"TERMINATED","sponsor":"University of Texas Southwestern Medical Center","startDate":"2020-12-01","conditions":"Bronchiolitis","enrollment":21},{"nctId":"NCT06970600","phase":"NA","title":"Efficacy of Artemether-Lumefantrine in the Treatment of Uncomplicated Plasmodium Falciparum Malaria in Children Under 12 Years at Four Sentinel Sites in Mozambique","status":"COMPLETED","sponsor":"Centro de Investigacao em Saude de Manhica","startDate":"2024-03-07","conditions":"Malaria (Uncomplicated)","enrollment":352},{"nctId":"NCT05723679","phase":"NA","title":"Targeting Breathing Limitations to Improve Functional Outcomes in HFpEF","status":"RECRUITING","sponsor":"University of Texas Southwestern Medical Center","startDate":"2023-07-01","conditions":"Heart Failure With Preserved Ejection Fraction, Obesity","enrollment":78},{"nctId":"NCT06946004","phase":"NA","title":"Normobaric Oxygen Therapy in Colorectal Cancer Patients","status":"NOT_YET_RECRUITING","sponsor":"4th Military Clinical Hospital with Polyclinic, Poland","startDate":"2025-11-01","conditions":"Colorectal Cancer (CRC)","enrollment":254},{"nctId":"NCT06622005","phase":"PHASE1","title":"SX-682 in Combination With Carfilzomib, Daratumumab-Hyaluronidase, and Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma","status":"RECRUITING","sponsor":"Roswell Park Cancer Institute","startDate":"2025-04-10","conditions":"Recurrent Multiple Myeloma, Refractory Multiple Myeloma","enrollment":15},{"nctId":"NCT06919237","phase":"NA","title":"Effects of Heart Rate Variability-guided Training vs Standard Aerobic Prescription on Cardiovagal Modulation and Cardiorespiratory Fitness in Coronary Artery Disease","status":"NOT_YET_RECRUITING","sponsor":"Faculdade de Motricidade Humana","startDate":"2025-09-01","conditions":"Coronary Arterial Disease (CAD)","enrollment":48},{"nctId":"NCT05635227","phase":"NA","title":"Dexamethasone, Olanzapine, Hemodynamics, and Ventilation in Cardiac Surgery","status":"RECRUITING","sponsor":"Rigshospitalet, Denmark","startDate":"2022-11-10","conditions":"Coronary Artery Disease, Aortic Valve Disease","enrollment":1200},{"nctId":"NCT04322994","phase":"NA","title":"THRIVE Use in Pediatric Populations- Multi Site","status":"COMPLETED","sponsor":"Stanford University","startDate":"2020-10-21","conditions":"Oxygen Deficiency, Desaturation of Blood, Hypoventilation","enrollment":175},{"nctId":"NCT05289310","phase":"NA","title":"Low Oxygen Exposure and Weight Status","status":"RECRUITING","sponsor":"Pennington Biomedical Research Center","startDate":"2023-05-16","conditions":"Obesity","enrollment":60},{"nctId":"NCT04958486","phase":"EARLY_PHASE1","title":"Combination Intraventricular Chemotherapy Pilot Study: 5-Azacytidine (5-AZA) and Trastuzumab Infusions Into the Fourth Ventricle or Resection Cavity in Children and Adults with Recurrent or Residual Posterior Fossa Ependymoma","status":"COMPLETED","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2021-07-08","conditions":"Fossa Ependymoma","enrollment":4},{"nctId":"NCT05633446","phase":"PHASE1, PHASE2","title":"Next Generation T-cell Vaccine Against Coronavirus Disease (COVID-19)","status":"NOT_YET_RECRUITING","sponsor":"Gylden Pharma Ltd","startDate":"2025-09-01","conditions":"Coronavirus, SARS-CoV-2 Infection, COVID-19","enrollment":110},{"nctId":"NCT04256798","phase":"PHASE3","title":"Perioperative Respiratory Care and Outcomes for Patients Undergoing High Risk Abdominal Surgery","status":"RECRUITING","sponsor":"University of Birmingham","startDate":"2020-11-13","conditions":"Infection, Pneumonia, Surgical Site Infection","enrollment":12942},{"nctId":"NCT06814652","phase":"","title":"The Impact of CYP2D6 Polymorphism on Tramadol Pharmacodynamics","status":"ACTIVE_NOT_RECRUITING","sponsor":"Elweyia Maternity Teaching Hospital","startDate":"2024-09-22","conditions":"Post-cesarean Pain, CYP2D6 Polymorphism, Tramadol Resistance","enrollment":40},{"nctId":"NCT03398200","phase":"PHASE2","title":"Effects of Hyperbaric Oxygen (HBO) on Blood Count Recovery After Autologous Hematopoietic Stem Cell (HSPC) Transplant for Multiple Myeloma","status":"COMPLETED","sponsor":"Omar Aljitawi","startDate":"2018-05-10","conditions":"Myeloma","enrollment":99},{"nctId":"NCT05681962","phase":"","title":"Practice of Oxygenation and Respiratory Support During Fiberoptic Bronchoscopy","status":"RECRUITING","sponsor":"University Magna Graecia","startDate":"2023-02-15","conditions":"Acute Respiratory Failure, Pneumonia, Lung Cancer","enrollment":10000},{"nctId":"NCT06493851","phase":"NA","title":"The Effect of Hyperbaric Oxygen Therapy for Acceleration Recovery After Anterior Cruciate Ligament Reconstruction(ACLR)","status":"RECRUITING","sponsor":"Assaf-Harofeh Medical Center","startDate":"2024-09-15","conditions":"Anterior Cruciate Ligament Reconstruction","enrollment":40},{"nctId":"NCT05028335","phase":"NA","title":"Effect of 1.5% Potassium Oxalate on the Control of Tooth Sensitivity and Color Change After Home Bleaching","status":"COMPLETED","sponsor":"Universidade Federal do Para","startDate":"2020-12-07","conditions":"Dentin Sensitivity","enrollment":50},{"nctId":"NCT06686238","phase":"NA","title":"Acute Effects of Intermittent Hypoxia-Hyperoxia in Older Adults","status":"NOT_YET_RECRUITING","sponsor":"Sierra Varona SL","startDate":"2024-12-05","conditions":"Older Adults, Cardiovascular Health, Blood Pressure","enrollment":16},{"nctId":"NCT06686316","phase":"NA","title":"Effects of Intermittent Hypoxia-Hyperoxia in Older Adults","status":"NOT_YET_RECRUITING","sponsor":"Sierra Varona SL","startDate":"2024-12-10","conditions":"Sedentary Behavior, Frailty, Older Adults","enrollment":16},{"nctId":"NCT06350864","phase":"NA","title":"HFNC Versus Conventional Oxygen Therapy in Prolonged Upper Gastrointestinal Endoscopy in the ICU","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2024-04-10","conditions":"Upper Gastrointestinal Bleeding","enrollment":70},{"nctId":"NCT05314543","phase":"NA","title":"Power-speed-endurance Profile (Cycling/Rowing) : Optimize Performance of the French Athletes at the Paris Olympics 2024","status":"COMPLETED","sponsor":"Centre Hospitalier Universitaire de Saint Etienne","startDate":"2021-11-29","conditions":"Healthy Volunteers, Performance","enrollment":19},{"nctId":"NCT05146700","phase":"PHASE4","title":"Restrictive Vs. Liberal Oxygen in Trauma","status":"COMPLETED","sponsor":"Rigshospitalet, Denmark","startDate":"2021-12-10","conditions":"Trauma, Oxygen Toxicity, Wounds and Injuries","enrollment":1508},{"nctId":"NCT05427760","phase":"NA","title":"Effect of Using Oxygen on the Diaper Dermatitis in Infants","status":"COMPLETED","sponsor":"Istanbul University - Cerrahpasa","startDate":"2022-10-15","conditions":"Diaper Rash, Diaper Dermatitis","enrollment":103},{"nctId":"NCT04472442","phase":"NA","title":"Intermittent Hypoxia Paired with High Intensity Training in Brain Injury","status":"COMPLETED","sponsor":"Indiana University","startDate":"2020-08-01","conditions":"Brain Injuries","enrollment":35},{"nctId":"NCT05343754","phase":"PHASE3","title":"Hyperbaric Oxygen Therapy for Pyoderma Gangrenosum","status":"TERMINATED","sponsor":"Erasmus Medical Center","startDate":"2022-06-01","conditions":"Pyoderma Gangrenosum","enrollment":3},{"nctId":"NCT04181359","phase":"PHASE1, PHASE2","title":"The Effect of Inhaled Nitric Oxide on Dyspnea and Exercise Tolerance in Interstitial Lung Disease.","status":"WITHDRAWN","sponsor":"University of Alberta","startDate":"2024-09-01","conditions":"Dyspnea","enrollment":""}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":96,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Oxygen 21 %","genericName":"Oxygen 21 %","companyName":"University of South Florida","companyId":"university-of-south-florida","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Oxygen 21% is a hyperoxic gas mixture that increases arterial oxygen partial pressure to enhance tissue oxygenation and potentially promote healing or therapeutic benefit in hypoxic conditions. Used for Hypoxic conditions or tissue hypoxia (specific indication unclear from limited information).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}